Kidney TransplantationTissue DonorsLiving DonorsTissue and Organ ProcurementGraft SurvivalTransplantation, HomologousDirected Tissue DonationCadaverGraft RejectionImmunosuppressive AgentsHistocompatibility TestingHistocompatibilityBone Marrow TransplantationGraft vs Host DiseaseTransplantsWaiting ListsHematopoietic Stem Cell TransplantationUnrelated DonorsTreatment OutcomeTransplantation ConditioningHeart TransplantationRetrospective StudiesAntilymphocyte SerumTransplantationWhole-Body IrradiationTime FactorsBlood DonorsLung TransplantationSurvival RateSurvival AnalysisRisk FactorsCyclosporineTacrolimusPostoperative ComplicationsImmunosuppressionCytomegalovirus InfectionsFetal Tissue TransplantationTransplantation ImmunologyMycophenolic AcidLiver FailureKidney Failure, ChronicImmunocompromised HostHeart-Lung TransplantationTransplantation, AutologousFollow-Up StudiesBrain Tissue TransplantationTransplantation, HeterotopicBronchiolitis ObliteransTransplantation ToleranceHLA AntigensCytomegalovirusRecurrenceOpportunistic InfectionsIsoantibodiesBK VirusBiopsyHematologic NeoplasmsKidneyBrain DeathGanciclovirTransplantation, IsogeneicProspective StudiesEnd Stage Liver DiseasePolyomavirus InfectionsLiver DiseasesIslets of Langerhans TransplantationLymphoproliferative DisordersCreatinineTissue and Organ HarvestingIncidenceKidney DiseasesAcute DiseasePostoperative PeriodPrimary Graft DysfunctionMycosesStem Cell TransplantationCorneal TransplantationAntiviral AgentsLeukemiaCord Blood Stem Cell TransplantationFatal OutcomePatient SelectionSkin TransplantationSirolimusPrognosisCohort StudiesBlood Group IncompatibilityT-LymphocytesRegistriesInfectionCalcineurinKaplan-Meier EstimateTissue TransplantationRisk AssessmentMultivariate AnalysisDrug Therapy, CombinationDeathRenal DialysisProportional Hazards ModelsAnemia, Aplastic